
Xoneklear 125mg Injection
Marketer
Mediklear Pharmaceuticals
Salt Composition
Ceftriaxone (125mg)
Overview Xoneklear 125mg Injection
Cephalosporin antibiotic Xoneklear, administered as a 125mg injection, combats bacterial infections throughout the body. Its applications encompass infections of the central nervous system (meningitis), respiratory system (pneumonia), ears, urinary tract, skin and soft tissues, musculoskeletal system, bloodstream, and cardiovascular system. Prophylactically, Xoneklear 125mg Injection may prevent surgical site infections. Administered intravenously or intramuscularly by a healthcare professional, dosage is determined individually. Consistent, evenly spaced dosing, as prescribed, is crucial; premature discontinuation risks infection recurrence or exacerbation. Commonly reported adverse effects include diarrhea, skin rash, altered liver function test results, and variations in blood cell counts (e.g., eosinophilia, leukopenia, thrombocytopenia). Transient injection site erythema or pain may occur. While generally mild, persistent or bothersome side effects warrant medical attention. Prior to treatment, disclose any antibiotic allergies, hepatic or renal impairment, and all concurrent medications, as interactions are possible.
Uses of Xoneklear 125mg Injection
Managing Bacterial Infections
Major Benefits of Xoneklear 125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Xoneklear 125mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Xoneklear 125mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Xoneklear 125mg Injection works:
Xoneklear 125mg Injection is a bactericidal antibiotic that works by disrupting bacterial cell wall synthesis, thus eliminating the bacteria's protective barrier and causing their death.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Xoneklear 125mg Injection.
PregnancySAFE IF PRESCRIBED
Xoneklear 125mg injections pose minimal to no documented risk to the fetus during gestation, according to the majority of research.
Breast feedingCAUTION
Administering Xoneklear 125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Xoneklear 125mg Injection can induce drowsiness, visual disturbances, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Individuals with kidney disease can safely receive Xoneklear 125mg Injection without a recommended dosage change. Nevertheless, disclosure of any pre-existing kidney conditions to your physician is advised.
LiverCAUTION
Exercise caution when administering Xoneklear 125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Altering the Xoneklear 125mg Injection dosage is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Xoneklear 125mg Injection :
Omit doses of Xoneklear 125mg Injection only after contacting your physician.
Facts to Know About Xoneklear 125mg Injection
| Label | Value |
|---|---|
| Chemical Category | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
